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Abstract
The measurement of different mercury compounds in human blood can provide valuable 
information about the type of mercury exposure. To this end, our laboratory developed a 
biomonitoring method for the quantification of inorganic (iHg), methyl (MeHg) and ethyl (EtHg) 
mercury in whole blood using a triple spike isotope dilution (TSID) quantification method 
employing capillary gas chromatography (GC) and inductively coupled dynamic reaction cell 
mass spectrometry (ICP-DRC-MS). We used a robotic CombiPAL® sample handling station 
featuring twin fiber-based solid phase microextraction (SPME) injector heads. The use of two 
SPME fibers significantly reduces sample analysis cycle times making this method very suitable 
for high sample throughput, which is a requirement for large public health biomonitoring studies. 
Our sample preparation procedure involved solubilization of blood samples with 
tetramethylammonium hydroxide (TMAH) followed by the derivatization with sodium tetra(n-
propyl)borate (NaBPr4) to promote volatility of mercury species. We thoroughly investigated 
mercury species stability in the blood matrix during the course of sample treatment and analysis. 
The method accuracy for quantifying iHg, MeHg and EtHg was validated using NIST standard 
reference materials (SRM 955c Level 3) and the Centre de Toxicologie du Québec (CTQ) 
proficiency testing (PT) samples. The limit of detection (LOD) for iHg, MeHg and EtHg in human 
blood was determined to be 0.27, 0.12, and 0.16 μg/L, respectively.
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Mercury is a non-essential toxic element occurring in the environment in different chemical 
forms including elemental (Hg), inorganic (iHg) and various organic forms such as methyl 
mercury (MeHg), ethyl mercury (EtHg), and others. Mercury adversely affects human well-
being; the manner in which it does depends on the chemical form of mercury (“species”), 
the route of entry into the body, length of exposure, and the age and susceptibility of the 
exposed person [1]. The most accepted biomarker of mercury exposure in humans is the 
direct measurement of mercury species in blood, which can aid in the identification of the 
exposure source and help guide treatment options [2,3]. From the perspective of improving 
the value of speciated mercury data from human exposure studies, it is essential that 
analytical laboratory performance benchmarks continue to advance.
Our laboratory supports a number of public health biomonitoring studies, such as the 
National Health and Nutrition Examination Survey (NHANES) [4] which includes the 
measurement of mercury species in human blood. National biomonitoring studies should 
measure any national or subpopulation initial exposures and monitor ongoing trends of 
analytes or their species that are of medical or public health concern. Additional analytical 
requirements include the ability to have the limit of detection (LOD) be approximately less 
than one third of the expected population mean; this ensures that the measurements are “fit 
for purpose”. Thus, it is clear that fast and robust methods with high accuracy, high 
precision, and low detection limits are important requirements for meeting the objectives of 
national surveys.
Solid-phase microextraction (SPME) paired with gas chromatography (GC) and inductively-
coupled plasma mass spectrometry (ICP-MS) has grown to become one of the more reliable 
technologies for the mercury speciation of biologic samples [2,5]. Despite the advances in 
instrumentation and sample introduction techniques, the mercury speciation methodology 
continued to be plagued by spontaneous in vitro transformation reactions resulting in 
unwanted changes, especially the dealkylation of organomercury compounds in biologic 
samples during processing or storage. Triple spike isotope dilution (TSID) is a particular 
useful technique that puts a number on how far species transformations have proceeded, so 
the analyst can apply the proper corrections [6]. Central to TSID design is that “spike” 
solution containing mixture of three mercury species standards, each synthesized to be 
enriched with different isotopes of mercury (199HgCl2, CH3200HgCl and C2H5201HgCl) 
must be added to each patient sample and equilibrated before mercury transformation 
reactions occur. Since the spike is chemically identical to the native form of mercury species 
contained in the sample, chemical transformations can be measured and mathematically 
corrected [7,8].
In this paper, we describe the development and characterization of a method for measuring 
iHg, MeHg and EtHg species in whole blood, which is intended for high throughput use in 
support of large human biomonitoring surveys. The TSID methodology offers us major 
improvements in accuracy, precision and LOD over our previous methods. We set goals for 
speed and efficiency, and we invested in a uniquely configured robotic CombiPAL® sample 
handling station featuring two SPME heads on the same workstation, which work together 
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in tandem. This arrangement allows the robot to perform a greater number of GC injections 
per hour without sacrificing optimum fiber extraction time. We validated our method for 
accuracy and precision using NIST standard reference material (SRM 955c Level 3) and 
Centre de Toxicologie du Québec (CTQ) proficiency testing (PT) samples. Further, we 
thoroughly investigated the stability of mercury species in whole blood during sample 
storage, preparation and analysis.
Experimental section
Detailed description of the experimental section can be found in Supplemental Information 
(SI).
Sample preparation
All reagents used were of analytical or reagent grade purity. Mercury speciation analysis of 
each 100 μL aliquot of blood sample began with the addition of 100 μL of spike solution 
containing known amounts of enriched 199HgCl2, CH3200HgCl and C2H5201HgCl isotopic 
standards (Applied Isotope Technologies (AIT), Sunnyvale, CA, USA), and immediately 
mixed by vortexing. After addition of 500 μL of tetramethylammonium hydroxide (TMAH), 
25% w/w in methanol (Alfa Aesar, Ward Hill, MA, USA), the samples were put in an 80 °C 
convection oven (FREAS Model 605, Thermo Fisher Scientific, USA) for 24–26 hours. 
Next, 200 μL of the solubilized sample was transferred to a 20 mL glass SPME analysis vial 
(Wheaton, Millville, NJ, USA) followed by the additions of 7.7 mL of 0.1 M sodium acetate 
buffer, pH 4.75, (bringing the final pH to 5–6) and 250 μL of 0.2% w/v of sodium tetra(n-
propyl)borate (NaBPr4) (ABCR, Germany). During the sample preparation procedure, the 
relative standard deviation (RSD) value associated with using the analytical balance was 
0.002% (N=10, 1g NIST certified weight), pipetting whole blood was 0.77% (N=10, 100 
μL), and pipetting the aqueous spike solution was 0.72% (N=10, 100 μL ). (See Figure S1 in 
SI for a diagrammatic representation of sample preparation and analysis.)
We prepared quality control (QC) samples using donated human whole blood purchased 
from Tennessee Blood Services (Memphis, TN, USA). “Low” (LB QC) and "high" (HB 
QC) pool contained concentrations of 0.8, 0.7, 0.6 and 2.2, 3.7, 1.2 μg/L for iHg, MeHg and 
EtHg, respectively (see SI, Table S1 for exact concentrations of each mercury species and 
detailed description of QC preparation). The empirical expanded uncertainties, U (k=2), for 
reported concentrations (μg/L) of iHg, MeHg and EtHg determined by our analytical method 
are ± 0.16, ± 0.11, and ± 0.13 for LB QC; ± 0.34, ± 0.34, and ± 0.21 for HB QC (Table S1 
in SI).
Instrumentation and data processing
Our laboratory measured the mercury analytes with an ELAN® DRC™ II ICP-MS 
(PerkinElmer Life Sciences, Shelton, CT, USA) operated in DRC mode (Argon gas, 0.3 mL/
min) which enhanced the mercury signal intensity (presumably by collisional focusing) [9], 
(see Table 1 for instrument settings and parameters). We used a PerkinElmer® Clarus 500™ 
gas chromatograph (PerkinElmer Life Sciences, Shelton, CT, USA) equipped with a GC 
capillary column (Perkin Elmer® Elite-5 30m, 0.25mm ID, 0.25μm of 5% diphenyl, 95% 
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polydimethylsiloxane, Shelton, CT, USA). The GC was coupled to the quadrupole ICP-MS 
by a heated GC transfer line (Redshift®, Italy, purchased though PerkinElmer Life 
Sciences). The transfer line’s capilliary tubing was threaded into the ICP-MS injector, 
stopping approximately 0.5 - 1 cm from the tip of the injector. This arrangement took 
advantage of the simplicity of direct injection, thereby avoiding the aerosol-gas mixing 
dynamics of a spray chamber that could negatively affect peak resolution and signal 
strength. Alternatively, the lack of a spray chamber meant we could not analyze liquid 
standards without removing the transfer line. We optimized the GC parameters for optimum 
peak retention and resolution (Table 1 and Figures S2 in SI). A CombiPAL® robotic 
sample processing workstation (CTC Analytics, Zwinger, Switzerland) performed SPME 
extractions and injections into the GC [10] (Table 1).
ICP-MS intensity signals of the three mercury species (iHg, MeHg and EtHg) were 
measured at m/z 198, 199, 200, 201 and 202. The 198Hg/202Hg, 199Hg/202Hg, 200Hg/202Hg, 
and 201Hg/202Hg peak area ratios were calculated and exported into a Microsoft Excel 
spreadsheet originally developed by Ouerdane and colleagues [11-13] where a 
deconvolution algorithm mathematically corrects for mercury species interconversions. 
Final mercury species concentrations were calculated using these isotope dilution equations. 
(Isotopic impurities associated with isotopically enriched mercury standards, provided in 
AIT certificate of analysis, were taken into the account.) Internal mass bias correction was 
applied according to the Meija and coworkers technique [14].
Additionally for method validation experiments, we used one-way ANOVA statistical data 
analysis to compare different experimental conditions. Scenarios with significant p-values 
(<0.05) were tested further for pairwise comparisons [15].
Results and discussion
The biomonitoring method described in this work quantifies iHg, MeHg and EtHg in whole 
blood using TSID-SPME-GC-ICP-DRC-MS. The sample preparation procedure involves 
addition of spike solution (isotopically labeled mercury species) to blood samples, followed 
by solubilization of blood with TMAH. Next, mercury species are derivatized with NaBPr4 
and the resulting volatile reaction products are sampled with a SPME fiber, followed by 
analysis using GC-ICP-MS (Figure S1 in SI presents the scheme of analytical procedures).
Sample preparation conditions
TSID spike solution—To calculate the ideal amount of spike to add to a sample, it is 
beneficial to know in advance the concentration of the analyte in question [6]. However, 
because of our need to develop a high throughput method and seeing the impracticability of 
prescreening a large number of samples for the purpose of calculating individual spike 
amounts for each sample, we pursued a different route. Specifically, we used one spike 
concentration that would work for most samples with mercury species present within a 
certain concentration range. Therefore, for each batch analysis we gravimetrically prepared a 
single spike solution having a precisely determined concentration of each isotope. We kept 
these concentrations as close as possible to 1 μg/L. This gave isotope ratios 
(199Hg/202Hg, 200Hg/202Hg, and 201Hg/202Hg) between one and three for HB QC (Table S2 
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in SI). Previous researchers have used spike:analyte ratios between one and three while 
keeping the uncertainty in their TSID measurements to a minimum [8,16]. We chose the 
spike:analyte ratio optimization for the HB QC sample because this sample’s total mercury 
concentration is not far from 5.13 μg/L, the 95th percentile of total blood mercury in the U.S. 
population [17].
To evaluate the effect of altering spike concentration, we analyzed LB QC and HB QC using 
spike solutions containing 0.5, 1.0, 2.5, 5.0, and 10.0 μg/L of each isotopically enriched 
mercury species (Table S2 in SI). Figures 1a and b show that for each spike level the 
measured concentrations fell inside the statistical control limits for each QC pool (Table S1 
in SI). For HB QC (Figure 1a), the measured mercury species concentrations remain 
constant throughout the entire 0.5–10.0 μg/L spike range; there is more absolute variability 
for LB QC but the relative variability is not much different from HB QC. Additionally, as 
will be discussed further in the dynamic analytical range section, using this method, we can 
analyze higher mercury concentrations using the 1 μg/L spike. Furthermore, in this 
experiment we calculated p-value to determine whether a statistically significant difference 
existed between the various spike concentrations that were tested. MeHg in the LB QC 
showed significance (p=0.04), Table S3 in SI. In the step-down tests, our new significance 
level was 0.05/10=0.005. We found that for MeHg in the LB QC, the mean at the higher 
spike level (10 μg/L) was significantly lower than the mean at the lower spike level of 1 
μg/L (mean of 0.640 μg/L vs. 0.733 μg/L, p=0.0042). However, it is important to note that 
statistical significance does not necessarily signify scientific importance. Since both 0.640 
μg/L and 0.733 μg/L are values that are well within our statistical control limits established 
for MeHg in our LB QC pool, we affirm our conclusion that there is no definitive evidence 
that one spike ratio is better than the other in the range of 0.5 to 10.0 μg/L for our method.
Solubilization—Due to the amount of protein and fat in blood, it is often necessary to use 
a strong acid or base to release metallic species [16]. We used TMAH to solubilize protein 
and release bound mercury species. At room temperature, it took approximately 72 hours to 
solubilize blood before iHg, MeHg and EtHg could be quantified (EtHg to iHg conversion 
of 63 ± 9%, N=12). To decrease the solubilization time, the blood samples were subjected to 
thermal treatment (“convection oven”) at 40°, 60°, 80°, 100° C for 24 hours. We found 80° 
C to be the optimum temperature providing highest mercury peak intensities (a detailed 
description can be found in the Sample solubilization section in SI). We evaluated the effect 
of oven time on the effectiveness of blood sample solubilization. LB and HB QC material 
were kept at 80 °C for 4, 8, 16, 20, 24 and 26 hours. Figures 1c and d present the MeHg 
results for this experiment. At 4 hours, we were not able to measure mercury species in LB 
QC and HB QC. At 8 hours, some measurements were possible but peak intensities were 
low, thus adversely affecting the calculated concentrations of the mercury species, especially 
for LB QC. After 16 hours, mercury species in LB and HB QC samples could be reliably 
measured as evidenced by results that fell inside their statistical control limits (Figures 1c). 
After 20, 24 and 26 hours, the results were again inside the QC statistical control limits. As 
expected, the MeHg chromatographic peak area increased as a function of the solubilization 
time (Figure 1d). iHg and EtHg showed the same trend (data not shown). We selected a 24 
to 26 hours oven time to obtain maximum peak intensities. We observed no clear increase in 
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standard deviation values for different solubilization times. There was no influence of 
solubilization time on the sample degradation with EtHg to iHg conversion of 61 ± 6, 60 ± 
5, 59 ± 4, and 58 ± 2 % at 16, 20, 24, and 26 hours, respectively. Please note these are 
“final” conversion percentages after all sample preparation steps and analysis 
(solubilization, derivatization, and injection of SPME into heated GC injector). During the 
solubilization step, EtHg to iHg conversion percent is approximately half of the final value. 
A detailed experimental description can be found in Sample solubilization section in SI. 
Furthermore, in this experiment, we used a p-value to evaluate the statistical significance 
between different solubilization times. EtHg in the LB QC showed significance (p=0.02) 
(Table S3 in SI). In the step-down tests, our new significance level was 0.05/6=0.008. The 
mean at a solubilization time of 24 hours was significantly lower than the mean at 20 hours 
(0.522 μg/L vs. 0.635 μg/L, p=0.02). Even in the presence of a statistically significant 
difference, it is important to note that both 0.522 μg/L and 0.635 μg/L are both within the 
EtHg statistical control limits established for LB QC (Table S1 in SI). Therefore, we state 
that the difference in the EtHg results between 20 and 24 hours is unimportant.
SPME sampling—In our method, we selected headspace sampling to prolong the lifetime 
of the SPME fiber by minimizing its exposure to the sample matrix [18]. Parameters such as 
volatility of analytes, the concentration of derivatization reagent, pH of the solution, 
extraction time and temperature, and desorption conditions that govern efficiency of SPME 
extraction were optimized (Figures S3 and S4 in SI).
Analytical characteristics of the method and stability studies
Freeze-thaw stability—In practice, it is occasionally necessary to repeat the analysis of 
some blood samples, which requires a second thawing and refreezing of the remaining 
sample. Some samples may undergo three or four freeze-thaw cycles. Therefore, we studied 
the stability of mercury species in blood after five freeze-thaw cycles. Groups of frozen LB 
QC and HB QC samples were thawed and refrozen up to five times (replicates of six) then 
analyzed for the mercury species concentration using our method. All samples after the 1st, 
2nd, 3rd, 4th, and 5th freeze-thaw cycles provided mercury species concentrations that were 
within the statistical control limits established for each QC pool (Figure S5 and Table S1 in 
SI). Thus, we concluded that mercury species are stable in blood after the repeated freeze-
thaw actions.
Room temperature stability—In the field where sample collections occur, it can be 
difficult to control the time lapse between the blood draw and the freezing of the sample. 
Because of this variability in time before samples get frozen, we investigated the stability of 
mercury species stored at room temperature. At various times equal to 0, 4, 8, 16, 20 and 24 
hours prior to analysis, we thawed out LB QC and HB QC samples in groups of three which 
were kept at 20–23 °C until all were analyzed for mercury species. Our measurements 
demonstrated that the aged samples produced mercury concentrations that were within our 
statistical control limits established for each QC pool at all time periods (Figure S6 and 
Table S1 in SI). The obtained result has confirmed that IHg, MeHg and EtHg species are 
stable in the blood matrix for up to 24 hours at room temperature.
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Stability following TMAH addition—If an analytical run needs to be repeated due to a 
problem not associated with sample preparation, it is appropriate to re-prepare the samples 
beginning with saved TMAH solubilized extract. In addition to saving time, it avoids the 
problem of re-thawing the same samples. To answer the question of whether mercury 
species are stable in TMAH, we repeatedly tested batches of LB QC and HB QC solubilized 
in TMAH addition for four months. The most important factor affecting stability for these 
samples is mercury species transformations. During routine sample pretreatment and 
analysis, approximately 35-55% of EtHg transforms to iHg (calculated using the 
deconvolution spreadsheet). We stored TMAH solubilized LB QC and HB QC (for QC pool 
concentrations refer to Table S4 in SI) at 20–23 °C and retested them periodically (in 
triplicate) for 134 days. Figure 2a displays the percentages of EtHg to iHg transformation as 
a function of time. The extent of EtHg to iHg transformation increased from 55% to 90% 
after four months. Interestingly, even at transformation up to 80%, LB QC and HB QC 
yielded concentrations within our statistical control limits for all three mercury species 
(Figures 2b, c, and d). When EtHg to iHg transformation exceeded 80%, results for EtHg 
and iHg started to fall outside their statistical control limits. At transformations exceeding 
90%, it became difficult to detect EtHg peaks in the chromatograms, making the calculation 
of the other mercury species in the same chromatogram impossible. Figure 2d shows that 
there is little change in the concentration distribution of MeHg as EtHg transforms into iHg. 
To conclude, the blood solubilized in TMAH is sufficiently stable to be reanalyzed for up to 
two months when stored at 20–23 °C. However, we have to take into the account that as the 
conversion rate reaches 80%, more error is seen with the analytical results obtained [19,7].
Final extract stability—As a part of our robustness testing, we wanted to determine if 
repeated SPME fiber extractions made on the same SPME vial would give consistent results. 
The CombiPal® autosampler was programmed to perform five consecutive fiber 
extraction/GC injection cycles on the same SPME vial at ~20 min intervals. This was done 
using four samples: LB QC, HB QC, LB QC diluted ten times with base blood (10X, 
concentration ≤ LOD for the method) and NIST SRM 955c Level 3. As expected, we 
observed a large incremental decrease in all peak areas following each re-extraction cycle 
(see Figure S7 and sample recovery section in SI). Nonetheless, the concentrations 
measured for the first extraction/GC injection cycle could be reproduced by each subsequent 
cycle for each sample. Further, it is important to know how stable are the mercury species in 
20 mL SPME vials once they are propylated, in case of a prolonged delay before the 
instrument is started. To address this, we prepared thirty samples of LB QC and HB QC for 
analysis through all steps including derivatization. The first ten samples were immediately 
analyzed while analysis of the remaining samples was delayed for 24 and 48 hours. The 
concentrations resulting from 24 and 48 hour delayed analysis fell outside the established 
QC limits (a finding confirmed by additional experimentation). Thus, we concluded that a 
steady loss of derivatized mercury species occurred. Therefore, it is important to avoid a 
prolonged delay of sample analysis once they have been derivatized.
Spike solution stability—Avoiding daily preparations of the spike solution can improve 
our method’s efficiency. Therefore, we tested the stability of the spike solution over the 
period of 29 days by observing changes in LB and HB QC concentrations prepared using the 
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same spike solution (Figure S8 in SI, four spike solutions were tested). LB and HB QC 
samples (four of each) were prepared with the same spike solution on days 1, 8, 15, 22, and 
29. All four spike solutions produced QC sample results for each species that were within 
our statistical quality control limits (Figure S8, Table S1 in SI). Thus, we concluded that it 
is safe to use a single preparation of spike solution for up to one month.
Additionally for freeze-thaw cycles, room temperature stability, and spike solution stability 
studies certain differences between the experimental conditions were statistically significant 
(Table S3 in SI). However, they were small and did not result in concentrations that 
exceeded their respective statistical control limits (detailed description can be found in SI).
Dynamic analytical range—Fundamental to the method performance is the linearity of 
signal response (i.e., dynamic range). In this method’s typical measurement protocol, we use 
pooled whole human blood (base blood) to dilute and reanalyze samples with individual 
mercury species concentrations > 10 μg/L. (This originates from the protocol of the CDC 
method used to measure total mercury.) Base blood has been predetermined to have no or 
minimal amounts of mercury species present. We wanted to establish whether or not there is 
a statistically significant difference between diluted and non-diluted elevated samples if the 
spike concentration is kept the same for all samples at 1 μg/L. Thus, we performed 
experiments analyzing CTQ PT samples with concentrations ranging from 10 – 90 μg/L in 
non-diluted and diluted (bringing concentration below 10 μg/L) forms (Figure 3a and Table 
S5 in SI). The results for diluted samples compared well to the non-diluted ones with a slope 
of 0.97 and r2=0.985 (Figure 3a). A Bland–Altman (B-A) difference plot comparing these 
two conditions displayed no clear bias (Figure S9a in SI). Furthermore, in this experiment 
we used a p-value to evaluate if there is a statistically significant difference between the 
diluted and non-diluted samples. A p-value of 0.4, (> 0.05) indicated that there is no 
statistically significant difference between the diluted and non-diluted samples. We 
compared the within-condition variability by calculating the coefficient of variation (CV %) 
for each condition (diluted vs. non-diluted) to be 8.27 vs. 4.04, respectively. Variability of 
results were higher (approximately double the value) under the dilute conditions. As of now, 
our laboratory is working on collecting enough patient data to show that in a selected 
concentration range, there is no need for diluting elevated samples with base blood prior to 
analysis.
Analytical figures of merit—The LODs for iHg, MeHg and EtHg were calculated to be 
0.27, 0.12, 0.16 μg/L, respectively. These limits are at least three times lower than the U.S. 
population average for total mercury blood concentrations [17] and are comparable to other 
published mercury speciation methods [20,21]. We evaluated short-term within-run 
analytical precision for this method by replicate analyses (n=8) of LB and HB QC samples 
for iHg, MeHg and EtHg species. The average RSD was approximately 3% (Figure S10 in 
SI). Uncertainty associated with the sample preparation procedure (weighing and pipetting) 
sum up to approximately 1 % RSD. More significant uncertainty contributions include 
instrumental drift, SPME sample introduction, and error associated with peak integration.
We verified the accuracy of the proposed methodology by analyzing whole blood NIST 
SRM 955c Level 3 and CTQ PT samples (Table 2 and Figure 3c, respectively). The 
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obtained NIST concentration values are the average of N=60 independent replicates 
collected over ten months on two separate instruments by two different analysts. The 
empirical expanded uncertainties, U (k=2), for reported concentrations (μg/L) of iHg, MeHg 
and EtHg for NIST determined by our analytical method are ± 1.6, ± 0.6, and ± 0.6 
respectively. NIST results for mercury species produced by this method fall within the 
allowable certified limits. We obtained RSD percentages of 8.3, 6.2, and 6.3 for iHg, EtHg 
and MeHg respectively (Table 2). It is important to note that these RSD values are without 
application of mass bias correction, Table 2. Additionally, we analyzed twenty-eight CTQ 
PT samples (refer to Table S5 in SI for the exact concentrations). These samples only 
contained iHg and MeHg. The results analyzed by our method compared very well to 
certified target values with a slope of 1.05 and r2=0.986 (all falling within certified ranges). 
B–A difference plot comparing certified CTQ values to the results from this method 
displayed no clear bias, Figure S9b in SI. The calculated p-value of 1 indicated that there 
was no statistically significant difference between certified values and values produced by 
this method.
Our choices of mass bias correction techniques were limited by the design of our GC-ICP-
MS interface. Instruments have been described that use a specially designed transfer line–
torch interface that incorporate an off-axis liquid spray chamber allowing liquid standards to 
be freely analyzed without removing the transfer line. Because we did not have this unique 
GC-ICP-MS interface, we could not analyze liquid external standards for mass bias 
correction unless we removed the transfer line and installed a spray chamber in its place. If 
performed in this manner, mass bias measurements using wet plasma can only be cautiously 
extrapolated to make estimates of the mass bias affecting chromatographically separated 
isotopes measured under dry conditions. Therefore, we alternatively employed an internal 
mass bias correction calculation (a form of the Russell exponential function) which depends 
merely on measuring the departure of the sample’s own isotope intensity pattern (not ratios) 
from the expected (pure component) pattern for each chromatographic peak [22]. Excel 
Solver® was used to iteratively find the mass bias correction coefficient K that gives the 
aggregate minimum of the sum squared error terms calculated from a multiple regression fit 
of the observed peak isotope patterns. Internal mass bias determinations are, in principle, 
free from errors coming from instrument instability and other temporally related causes of 
imprecision.
After finalizing the instrument parameters and optimization procedure, we monitored K 
while analyzing numerous blood samples including internal QC, NIST 955c Level 3, and 
other samples over the course of several months. What we found is, with only a few 
exceptions, K did not significantly differ from zero. Using NIST 955c Level 3 as an 
example, after 55 independent single sample measurements (i.e., each done on a separate 
day), the one-sample T-Test mean (confidence intervals, α=0.05) for K was −0.0009 
(−0.0027, 0.0009) indicating that K was not insignificantly different from zero. Even when 
the differences in final resulting concentrations between mass bias corrected and uncorrected 
results were statistically compared using paired T-Test (α=0.05, n=55), no significant 
differences were found (p=0.21, 0.12 and 0.23 for IHg, MeHg and EtHg, respectively). On 
the other hand, correcting for mass bias gave slightly larger run-to-run variation (corrected 
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v. uncorrected RSD): IHg, 9.6% v. 8.2%; MeHg, 7.2% v. 6.3%; EtHg, 8.2% v. 6.8%. We 
realized that there would be no practical benefit by routinely correcting for mass bias for the 
following reasons: 1) the change in concentration resulting from mass bias correction was 
<1% compared to the overall run-to-run variability and 2) applying mass bias correction 
caused run-to-run variability to noticeably increase. Therefore, we decided to stop making 
corrections for mass bias and instead monitor K as a quality assurance indicator.
Conclusions
Our laboratory developed a rapid, accurate and precise biomonitoring method for the 
quantification of iHg, MeHg and EtHg in whole blood using TSID-SPME-GC-ICP-DRC-
MS. We proved that optimized headspace extraction by a dual arm SPME setup is a fast and 
sensitive approach in providing capability for high sample throughput. Additionally, the 
TSID technique clearly demonstrated its superior capability in overcoming precision 
shortcomings historically associated with the SPME sampling technique. The method’s 
within-run average analytical precision (RSD %) for all three mercury species in LB and HB 
QC samples analyzed after eight replicates was approximately 3%. We achieved 
interference free GC separation of the three mercury analytes with excellent selectivity. 
With the optimized sample preparation, SPME sampling, GC-separation, and ICP-MS 
detection we determined the limits of detection for iHg, MeHg and EtHg species in human 
blood matrix to be 0.27, 0.12, 0.16 μg/L, respectively. We validated the accuracy of the 
method through the analysis of certified reference materials and proficiency testing samples. 
An accurate and high throughput mercury speciation method is a necessary tool for 
providing valuable information about the source of mercury exposure in humans. Future 
work with this method will include reducing the solubilization time to make the method 
better suited for high sample throughput and faster response times.
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Refer to Web version on PubMed Central for supplementary material.
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Concentration changes of iHg, MeHg and EtHg in (a) HB QC and (b) LB QC samples 
prepared with spike solutions containing different concentrations of isotopically enriched 
mercury standards (0.5, 1.0, 2.5, 5.0, and 10.0 μg/L). The results shown in the graphs are the 
averages of all replicates (N=6) at each of the different spike concentrations. (c) 
Concentration of MeHg in HB and LB QC material as a function of sample solubilization 
times (4, 8, 16, 20, 24 and 26 hours). (d) Changes in MeHg peak area as a function of the 
sample solubilization times. The results shown above are the averages of the replicates 
(N=6) from the different solubilization time intervals. The 95th percentile confidence 
intervals are shown as error bars.
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Blood solubilization stability study. (a) Monitoring EtHg to iHg species interconversions 
percentages as a function of time. (b), (c), and (d) Present iHg, MeHg and EtHg 
concentrations, respectively, in HB and LB QC material as species conversion percentages 
(EtHg to iHg) increase over time (t = 2→134 days). The solid black line represents 
established QC concentrations while the dotted line represents the QC limits. (A different 
QC pool is used for this experiment; see Table S4 in SI for exact concentrations. This pool 
was used prior to the characterization of a new QC pool, Table S1 in SI.)
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(a) Comparison of dilute and non-diluted CTQ PT samples (slope=0.97 and r2=0.985, p-
value of 0.4), (b) comparison of observed values vs. consensus means for CTQ PT samples 
(slope=1.05 and r2=0.986, p-value of 1).
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Table 1
Optimal operating conditions for mercury speciation method.
ICP-DRC-MS
Carrier Ar gas flow 1.5 L/min
Auxiliary Ar gas flow 1.2 L/min*
Plasma Ar gas flow 15 L/min*
Lens voltage 4.75 V*
RF Power 1450 W*
DRC Mode QRO − 10 V*
DRC Mode CRO − 1V*
DRC Mode CPV − 55 V*
Cell Gas A Ar at 0.3 mL/min*
DRC rejection parameter q (RPq) 0.3*
Scanning mode Peak hopping
Dwell time 25 ms
Sweeps per reading 1
Readings per replicate 2725
Number of replicates 1
Dead time 60 ns
Isotopes monitored 198, 199, 200, 201, 202
Measurement time per sample 20 min
GC
GC injector temperature 220°C (1 min), max ramp to 280°C, hold
Carrier gas / flow rate He / 2 mL/min
Oven program 75°C (1 min) to 250°C (2 min) (at rate = 45 °C/min)
Transfer line temperature 250°C
Injection mode splitless
Autosampler
Needle penetration 35.0 mm
Extraction temperature Room temperature (approximately 25.7°C)
SPME
Fiber coating 100 μm PDMS
Sampling mode Head space
Enrichment Time 1200 s
Desorption Time 420 s
GC Cooling Down 180 s
*
Suggested starting values only. Optimum parameters will depend on outcome of the optimization procedure and the instrument being used.
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Table 2
Certified mean mercury concentration values (μg/L) provided by the National Institute of Standards and 
Technology (NIST) and mean mercury concentration values (μg/L) produced by our method at CDC for 
reference material NIST SRM 955c Level 3 (Caprine blood). The obtained concentration values are the 
average of N=60 independent replicates collected over ten months on two separate instruments by two 
different analysts.
NIST SRM 955c Level 3 EtHg iHg MeHg TotalHg
μg/L
CDC Mean 5.0 9.1 5.0 19.1
Standard Deviation 0.3 0.8 0.3 0.9
Relative Standard Deviation (%) 6.2 8.3 6.3 4.6
NIST Certified Mean 5.1 9.0 4.5 17.8
Expanded Error (k=2) 0.5 1.3 1.0 1.6
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